Dandy–Walker Malformation: an Incidental Finding Case Report
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
1Q21.1 Duplication Syndrome and Epilepsy Case Report and Review
CLINICAL/SCIENTIFIC NOTES OPEN ACCESS 1q21.1 Duplication syndrome and epilepsy Case report and review Ioulia Gourari, MD, Romaine Schubert, MD, and Aparna Prasad, PhD Correspondence Dr. Gourari Neurol Genet 2018;4:e219. doi:10.1212/NXG.0000000000000219 [email protected] Copy number variants (CNVs) of 1q21.1 are increasingly being recognized due to the wide- spread use of genetic screening tests for the investigation of developmental disorders and epilepsy. These include microdeletion and microduplication syndromes, associated with a wide variety of pathology including autism spectrum disorders, attention-deficit disorder, learning disabilities, hypotonia, facial dysmorphisms, and schizophrenia. The 1q21.1 region is consid- ered to be genetically unstable because it contains one of the largest areas of identical dupli- cation sequences in the human genome. Epilepsy has been reported in the literature, particularly in microdeletion syndromes, but rarely in association with microduplication syn- dromes. We report a patient with epilepsy and autism spectrum disorder due to a distal 1q21.1 microduplication and review the available literature and genetic information. Case report We present a 10-year-old girl with a low-functioning autism spectrum disorder and focal motor epilepsy. On examination, she has hypertelorism, minimal communicative language skills, and severe macrocephaly (HC = 57 cm, 3.6 SD > 99%). Seizures started at 7 years of age and consisted of head deviation to the left, generalized stiffening, clonic activity of the mouth, and fluttering of the eyelids, lasting for 1–2 minutes. Multiple video EEG recordings showed a right temporal focus with a less active, independent left temporal focus. 3T MRI scan of the brain was normal. -
Megalencephaly and Macrocephaly
277 Megalencephaly and Macrocephaly KellenD.Winden,MD,PhD1 Christopher J. Yuskaitis, MD, PhD1 Annapurna Poduri, MD, MPH2 1 Department of Neurology, Boston Children’s Hospital, Boston, Address for correspondence Annapurna Poduri, Epilepsy Genetics Massachusetts Program, Division of Epilepsy and Clinical Electrophysiology, 2 Epilepsy Genetics Program, Division of Epilepsy and Clinical Department of Neurology, Fegan 9, Boston Children’s Hospital, 300 Electrophysiology, Department of Neurology, Boston Children’s Longwood Avenue, Boston, MA 02115 Hospital, Boston, Massachusetts (e-mail: [email protected]). Semin Neurol 2015;35:277–287. Abstract Megalencephaly is a developmental disorder characterized by brain overgrowth secondary to increased size and/or numbers of neurons and glia. These disorders can be divided into metabolic and developmental categories based on their molecular etiologies. Metabolic megalencephalies are mostly caused by genetic defects in cellular metabolism, whereas developmental megalencephalies have recently been shown to be caused by alterations in signaling pathways that regulate neuronal replication, growth, and migration. These disorders often lead to epilepsy, developmental disabilities, and Keywords behavioral problems; specific disorders have associations with overgrowth or abnor- ► megalencephaly malities in other tissues. The molecular underpinnings of many of these disorders are ► hemimegalencephaly now understood, providing insight into how dysregulation of critical pathways leads to ► -
Orphanet Report Series Rare Diseases Collection
Marche des Maladies Rares – Alliance Maladies Rares Orphanet Report Series Rare Diseases collection DecemberOctober 2013 2009 List of rare diseases and synonyms Listed in alphabetical order www.orpha.net 20102206 Rare diseases listed in alphabetical order ORPHA ORPHA ORPHA Disease name Disease name Disease name Number Number Number 289157 1-alpha-hydroxylase deficiency 309127 3-hydroxyacyl-CoA dehydrogenase 228384 5q14.3 microdeletion syndrome deficiency 293948 1p21.3 microdeletion syndrome 314655 5q31.3 microdeletion syndrome 939 3-hydroxyisobutyric aciduria 1606 1p36 deletion syndrome 228415 5q35 microduplication syndrome 2616 3M syndrome 250989 1q21.1 microdeletion syndrome 96125 6p subtelomeric deletion syndrome 2616 3-M syndrome 250994 1q21.1 microduplication syndrome 251046 6p22 microdeletion syndrome 293843 3MC syndrome 250999 1q41q42 microdeletion syndrome 96125 6p25 microdeletion syndrome 6 3-methylcrotonylglycinuria 250999 1q41-q42 microdeletion syndrome 99135 6-phosphogluconate dehydrogenase 67046 3-methylglutaconic aciduria type 1 deficiency 238769 1q44 microdeletion syndrome 111 3-methylglutaconic aciduria type 2 13 6-pyruvoyl-tetrahydropterin synthase 976 2,8 dihydroxyadenine urolithiasis deficiency 67047 3-methylglutaconic aciduria type 3 869 2A syndrome 75857 6q terminal deletion 67048 3-methylglutaconic aciduria type 4 79154 2-aminoadipic 2-oxoadipic aciduria 171829 6q16 deletion syndrome 66634 3-methylglutaconic aciduria type 5 19 2-hydroxyglutaric acidemia 251056 6q25 microdeletion syndrome 352328 3-methylglutaconic -
What Is Your Diagnosis?
Photo Quiz What Is Your Diagnosis? CUTIS Do Not Copy A 6-week-old male infant was referred to the dermatology department for evaluation of enlarging facial lesions noted shortly after birth. The patient was delivered at 36 weeks’ gestation by normal spontaneous vaginal delivery with no perinatal complications. His growth and development were otherwise nor- mal. Physical examination revealed large, bright red, nonconfluent macules and plaques in a bilateral temporal distribution extending medially to both eye- lids and laterally to the scalp. PLEASE TURN TO PAGE 119 FOR DISCUSSION Shilpa S. Sawardekar, MD; Heather L. Salvaggio, MD; Andrea L. Zaenglein, MD Drs. Sawardekar and Salvaggio were from and Dr. Zaenglein is from the Department of Dermatology and Pediatrics, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania. Dr. Sawardekar currently is from the Department of Dermatology, Eastern Virginia Medical School, Norfolk. Dr. Salvaggio currently is from the Division of Dermatology, Bassett Medical Center, Cooperstown, New York. The authors report no conflict of interest. Correspondence: Andrea L. Zaenglein, MD, Department of Dermatology, HU14, Penn State Milton S. Hershey Medical Center, 500 University Dr, Hershey, PA 17033 ([email protected]). WWW.CUTIS.COM VOLUME 92, SEPTEMBER 2013 113 Copyright Cutis 2013. No part of this publication may be reproduced, stored, or transmitted without the prior written permission of the Publisher. Photo Quiz Discussion The Diagnosis: PHACE Syndrome CUTIS HACE (posterior fossa brain malformations, syndrome is made in the following scenarios: a large hemangiomas, arterial anomalies, cardiac hemangioma greater than 5 cm plus 1 minor crite- Pdefects and coarctation of the aorta, eye and ria, a hemangioma of the neck or upper torso plus endocrine abnormalities) syndrome is a neurocu- 1 major or 2 minor criteria, or no hemangioma plus taneousDo disorder characterized Not by a spectrum of 2 major Copy criteria.4 abnormalities. -
South Carolina Birth Defects Program Resource Guide
South Carolina Birth Defects Program Resource Guide A South Carolina where healthy births are promoted, every birth defect matters, and families impacted by birth defects are supported. Table Of Contents Introduction Introduction 1 Thousands of families in South Carolina have been impacted by a birth defect. Birth defects are structural changes which are already there when a baby is born that can affect any part of the body (e.g., heart, brain, South Carolina Birth Defects Program Mission and Vision 2 foot). They may affect how the body looks, works, or both. Birth defects can vary from mild to severe. The well-being of each child affected with a birth defect depends mostly on which organ or body part is involved, General Information on Birth Defects in South Carolina 4 how much it is affected, early detection, and timely entry into Early Intervention services. Cardiovascular (Heart) Birth Defects in South Carolina 5 Learning that a child has a birth defect can be difficult for a family. Families often feel alone when they find out about a birth defect. They are not alone. According to the Centers for Disease Control and Prevention, birth Interview with a Parent of a Child with a Critical Congenital Heart Birth Defect 7 defects affect 1 in 33 babies born every year and cause 1 in 5 infant deaths. In 2004, South Carolina government officials created a way to track these important conditions through a law called “The South Carolina Birth Orofacial Birth Defects 11 Defects Act.” The South Carolina Birth Defects Program (SCBDP) was created through this law. -
Endosomal Trafficking Defects Alter Neural Progenitor Proliferation And
bioRxiv preprint doi: https://doi.org/10.1101/2020.08.17.254037; this version posted August 17, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. 1 2 Endosomal trafficking defects alter neural progenitor proliferation 3 and cause microcephaly 4 5 Jacopo A. Carpentieri1, Amandine Di Cicco1, David Andreau1, Laurence Del Maestro2, Fatima 6 El Marjou1, Laure Coquand1, Jean-Baptiste Brault1, Nadia Bahi-Buisson3, Alexandre D. 7 Baffet1,4,# 8 9 1- Institut Curie, PSL Research University, CNRS UMR144, 75005 Paris, France 10 2- Centre Épigénétique et destin cellulaire, Université Paris Diderot, CNRS UMR 7216, 75013 Paris, 11 France 12 3- INSERM U1163, Institut Imagine, Necker Hospital, 75015 Paris, France 13 4- Institut national de la santé et de la recherche médicale (Inserm) 14 # Corresponding author: [email protected] 15 16 Abstract 17 Primary microcephaly and megalencephaly are severe brain malformations defined by reduced 18 and increased brain size, respectively. Whether these two pathologies arise from related alterations at 19 the molecular level is unclear. Microcephaly has been largely associated with centrosomal defects, 20 leading to cell death. Here, we investigated the consequences of WDR81 loss of function, which cause 21 severe microcephaly in patients. We show that WDR81 regulates endosomal trafficking of EGFR, 22 and that loss of function leads to reduced MAP kinase pathway activation. Mouse radial glial 23 progenitor cells knocked-out for WDR81 display reduced proliferation rates, leading to reduced brain 24 size. -
Proximal Microdeletions and Microduplications of 1Q21.1 Contribute to Variable Abnormal Phenotypes
European Journal of Human Genetics (2012) 20, 754–761 & 2012 Macmillan Publishers Limited All rights reserved 1018-4813/12 www.nature.com/ejhg ARTICLE Proximal microdeletions and microduplications of 1q21.1 contribute to variable abnormal phenotypes Jill A Rosenfeld1, Ryan N Traylor1, G Bradley Schaefer2, Elizabeth W McPherson3, Blake C Ballif1, Eva Klopocki4, Stefan Mundlos4, Lisa G Shaffer*,1 and Arthur S Aylsworth5, 1q21.1 Study Group6 Chromosomal band 1q21.1 can be divided into two distinct regions, proximal and distal, based on segmental duplications that mediate recurrent rearrangements. Microdeletions and microduplications of the distal region within 1q21.1, which are susceptibility factors for a variety of neurodevelopmental phenotypes, have been more extensively studied than proximal microdeletions and microduplications. Proximal microdeletions are known as a susceptibility factor for thrombocytopenia-absent radius (TAR) syndrome, but it is unclear if these proximal microdeletions have other phenotypic consequences. Therefore, to elucidate the clinical significance of rearrangements of the proximal 1q21.1 region, we evaluated the phenotypes in patients identified with 1q21.1 rearrangements after referral for clinical microarray testing. We report clinical information for 55 probands with copy number variations (CNVs) involving proximal 1q21.1: 22 microdeletions and 20 reciprocal microduplications limited to proximal 1q21.1 and 13 microdeletions that include both the proximal and distal regions. Six individuals with proximal microdeletions have TAR syndrome. Three individuals with proximal microdeletions and two individuals with larger microdeletions of proximal and distal 1q21.1 have a ‘partial’ TAR phenotype. Furthermore, one subject with TAR syndrome has a smaller, atypical deletion, narrowing the critical deletion region for the syndrome. -
Miller–Dieker Syndrome, Type 1 Lissencephaly
Journal of Perinatology (2008) 28, 313–315 r 2008 Nature Publishing Group All rights reserved. 0743-8346/08 $30 www.nature.com/jp IMAGING CASE BOOK Miller–Dieker syndrome, type 1 lissencephaly TE Herman and MJ Siegel Department of Radiology, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, MO, USA Journal of Perinatology (2008) 28, 313–315; doi:10.1038/sj.jp.7211920 bitemporal shallowness. The ears were low set. Retromicrognathia, and microphthalmia, more marked on the left, were also present. Case presentation The child had a cranial sonogram (Figure 1) and cranial magnetic A 1910 g infant was born at 41-weeks gestation to a 19-year-old resonance imaging (Figure 2). gravida 1 mother after a pregnancy complicated by hydramnios and poor fetal movement. The child was delivered by a cesarean section because of fetal decelerations with labor. Severe intrauterine Denouement and discussion growth retardation was present with the infant’s weight, length and The cranial sonogram demonstrated an abnormally smooth brain head circumference all less than the tenth percentile for gestational with no gyration or sulcation with a wide, shallow sylvian fissure age. The patient’s head demonstrated a wasted appearance with creating a figure-of-8 appearance. The absence of all gyri is Figure 1 (a) Coronal cranial sonogram at the level of the third ventricle demonstrating a figure-of-8 appearance of the brain with wide sylvian fissure and with no sulci or gyri. (b) Sagittal right lateral cranial sonogram demonstrating absence of gyri over the ipsilateral hemisphere. (c) Right sagittal sonogram demonstrating echogenic linear thalamostriate vessels (arrow). -
PHACE Syndrome by Cristina Camacho
www.ComplexChild.com PHACE Syndrome by Cristina Camacho At four weeks old, our baby girl, Elyse, was diagnosed with PHACE Syndrome. This uncommon condition wasn't even known until 1996 when Dr. Ilona J. Frieden, director of Pediatric Dermatology at UCSF Children's Hospital, and her colleagues first used the acronym PHACE to describe it. The word PHACE is an acronym that describes these symptoms: P Posterior fossa malformations (brain malformations) H Large segmented Hemangioma (mainly on the face) A Arterial anomalies of the head and neck C Coarctation of the aorta and cardiac defects E Eye anomalies Children with PHACE Syndrome mainly have one thing in common, a large facial hemangioma or benign tumor sometimes known as a strawberry birthmark. Other symptoms vary in each child. Some children have more life threatening symptoms, while others just have mild symptoms. In Elyse’s case, she had life threatening symptoms that required her to be hospitalized most of her first year and receive home nursing care. When Elyse was diagnosed, there were only 200 reported cases of PHACE. There are no known causes and it is not hereditary. This condition is also more common in girls than in boys. It is important that a child suspected to have PHACE be evaluated by a multidisciplinary vascular anomalies team that includes pediatric dermatology, cardiology and ophthalmology. Testing will include a head and chest MRI/MRA, and an echocardiogram of the heart. Elyse's Story When I was pregnant with Elyse, there were no warning signals, and my pregnancy was completely normal. We were expecting a little girl and couldn’t have been happier. -
Phace Syndrome P
DOI: 10.14260/jemds/2015/324 CASE REPORT A RARE CASE REPORT: PHACE SYNDROME P. Indira1, A. Swamynaidu2, N. Jayalaxmi3 HOW TO CITE THIS ARTICLE: P. Indira, A. Swamynaidu, N. Jayalaxmi. “A Rare Case Report: Phace Syndrome”. Journal of Evolution of Medical and Dental Sciences 2015; Vol. 4, Issue 13, February 12; Page: 2239-2240, DOI: 10.14260/jemds/2015/324 INTRODUCTION: A syndrome is defined as a recognizable pattern of medical conditions that occur together. Initially described as an association of large cutaneous hemangiomas of the head and anomalies of the cerebral vasculature by pascual-castroviejo in 1978. Subsequently been coined the term PHACE association by Frieden et.al. Frieden created the term PHACE, which is an acronym which refers to Posterior fossa anomalies, Hemangioma, Arterial lesions, Cardiac abnormalities/ coarctation of the aorta and Eye anomalies. PHACES SYNDROME is PHACE syndrome plus: Sternal cleft, supraumbilical raphe, or both. CASE REPORT: A 6 yrs old male child presented with red colour patch over left side of face since birth and progressive increase in size and decrease in vision of the left eye. On examination, the child had an erythematous patch mainly on the left side of face. An ophthalmic examination of the left side revealed micro-opthalmous and microcornea with corneal opacity. Examination of other systems was unremarkable. Echocardiography was normal, Magnetic Resonance Imaging (MRI) of orbits and brain showed the presence of Hemangioma in left temporal fossa and periorbital soft tissues with intraorbital extension and coloboma of left eye, hypoplastic left cerebellar hemisphere and left unilateral megalencephaly with prominent sulci/cisterns. -
Spd 2014 Poster Presentations
SPD 2014 POSTER PRESENTATIONS ABSTRACT OWNER TITLE CATEGORY Admani, Shehla Countering Staphylococcus Atopic Dermatitis Overgrowth During Patch Testing in Moderate-Severe Atopic Dermatitis Patients Aggarwal, Smita A Rare Case of Sinus Pericranii Vascular Lesions Arca, Ercan Clinical and dermoscopic features Tumors/Neoplasms of congenital melanocytic nevi in Turkish children Barrick, Benjamin Penile and scrotal edema: an under Psoriasis/Inflammatory Skin recognized presentation of Crohn’s Conditions Disease Bayart, Cheryl Refractory Pyoderma Gangrenosum Psoriasis/Inflammatory Skin Associated with Chronic Recurrent Conditions Multifocal Osteomyelitis: Novel Therapeutic Options Bercovitch, Lionel Iatrogenic acquired acrodermatitis Miscellaneous enteropathica associated with treatment of hypermanganesemia in an era of trace element shortage Brandt, Staci Cutaneous Tolerability and Subject Medications/Therapies Satisfaction of an Over the Counter Cleansing and Moisturizing Regimen in Subjects Aged 7 to 11 Years With Acne Prone Skin Brandt, Staci Tolerability and Cosmetic Atopic Dermatitis Acceptability of a Body Wash in Atopic Dermatitis Prone Subjects SPD 2014 POSTER PRESENTATIONS ABSTRACT OWNER TITLE CATEGORY Caldwell, Chauncey The Prevalence of Alopecia Areata Miscellaneous Among 572,617 Pediatric Patients Seen in Dermatology Private Practices throughout the United States Chiu, Yvonne Analysis of Systemic Sclerosis Psoriasis/Inflammatory Skin Candidate Genes from Whole Conditions Exome Sequencing of Pediatric Morphea Lesional Tissue Diaz, -
Table I. Genodermatoses with Known Gene Defects 92 Pulkkinen
92 Pulkkinen, Ringpfeil, and Uitto JAM ACAD DERMATOL JULY 2002 Table I. Genodermatoses with known gene defects Reference Disease Mutated gene* Affected protein/function No.† Epidermal fragility disorders DEB COL7A1 Type VII collagen 6 Junctional EB LAMA3, LAMB3, ␣3, 3, and ␥2 chains of laminin 5, 6 LAMC2, COL17A1 type XVII collagen EB with pyloric atresia ITGA6, ITGB4 ␣64 Integrin 6 EB with muscular dystrophy PLEC1 Plectin 6 EB simplex KRT5, KRT14 Keratins 5 and 14 46 Ectodermal dysplasia with skin fragility PKP1 Plakophilin 1 47 Hailey-Hailey disease ATP2C1 ATP-dependent calcium transporter 13 Keratinization disorders Epidermolytic hyperkeratosis KRT1, KRT10 Keratins 1 and 10 46 Ichthyosis hystrix KRT1 Keratin 1 48 Epidermolytic PPK KRT9 Keratin 9 46 Nonepidermolytic PPK KRT1, KRT16 Keratins 1 and 16 46 Ichthyosis bullosa of Siemens KRT2e Keratin 2e 46 Pachyonychia congenita, types 1 and 2 KRT6a, KRT6b, KRT16, Keratins 6a, 6b, 16, and 17 46 KRT17 White sponge naevus KRT4, KRT13 Keratins 4 and 13 46 X-linked recessive ichthyosis STS Steroid sulfatase 49 Lamellar ichthyosis TGM1 Transglutaminase 1 50 Mutilating keratoderma with ichthyosis LOR Loricrin 10 Vohwinkel’s syndrome GJB2 Connexin 26 12 PPK with deafness GJB2 Connexin 26 12 Erythrokeratodermia variabilis GJB3, GJB4 Connexins 31 and 30.3 12 Darier disease ATP2A2 ATP-dependent calcium 14 transporter Striate PPK DSP, DSG1 Desmoplakin, desmoglein 1 51, 52 Conradi-Hu¨nermann-Happle syndrome EBP Delta 8-delta 7 sterol isomerase 53 (emopamil binding protein) Mal de Meleda ARS SLURP-1